Skip to main content

Zevra Therapeutics, Inc 10-Q for FY2023 Q2

Zevra Therapeutics, Inc. (ZVRA)

10-Q 2023-08-14 For: 2023-06-30
View Original
Added on April 10, 2026

About this 10-Q

Zevra Therapeutics, Inc filed this 10-Q on August 14, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).

Headline figures

Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$8.47M
up 551.5% from $1.3M a year earlier
Net loss
$5.08M
compared with a net loss of $24.04M a year earlier